Betel-quid use is associated with heart disease in women

American Journal of Clinical Nutrition

Volumn 85, Issue 5, 2007, Pages 1229-1235

  Guh, Jinn Yuh ^a   Chen, Hung Chun ^a   Tsai, Jung Fa ^a   Chuang, Lea Yea ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Areca catechu; Betel quid; Diabetes; Framingham risk score; Heart disease; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; BETEL QUID; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HUMAN; MALE; OBESITY; PREVALENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SPICE; TRIACYLGLYCEROL BLOOD LEVEL; WOMEN'S HEALTH;

ARECA CATECHU; PIPER BETEL;

EID: 34248362375     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.5.1229     Document Type: Article

References (52)

1. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291:2616-22.
2. Lawes CM, Rodgers A, Bennett DA, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003;21:707-16.
3. Anonymous. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Tolstrup J, Jensen MK, Tjonneland A, Overvad K, Mukamal KJ, Gronbaek M. Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ 2006;332:1244-8.
5. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82-96.
6. Lutz W, Sanderson W, Scherbov S. The end of world population growth. Nature 2001;412:543-5.
7. Mascie-Taylor CG, Karim E. The burden of chronic disease. Science 2003;302:1921-2.
8. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
9. Bonow RO, Gheorghiade M. The diabetes epidemic: a national and global crisis. Am J Med 2004;116(suppl):2S-10S.
10. Chan JC, Ng MC, Critchley JA, Lee SC, Cockram CS. Diabetes mellitus - a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract 2001;54(suppl):S19-27.
11. Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002;106:2137-42.
12. Lei D, Chan CP, Wang YJ, et al. Antioxidative and antiplatelet effects of aqueous inflorescence Piper betle extract. J Agric Food Chem 2003;51:2083-8.
13. Boucher BJ, Mannan N. Metabolic effects of the consumption of Areca catechu. Addict Biol 2002;7:103-10.
14. Tsai JF, Jeng JE, Chuang LY, et al. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore) 2004;83:176-87.
15. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004;85:1-334.
16. Yen AM, Chiu YH, Chen LS, et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 2006;83:1153-60.
17. Mannan N, Boucher BJ, Evans SJ. Increased waist size and weight in relation to consumption of Areca catechu (betel-nut); a risk factor for increased glycaemia in Asians in east London. Br J Nutr 2000;83:267-75.
18. Guh JY, Chuang LY, Chen HC. Betel-quid use is associated with the risk of the metabolic syndrome in adults. Am J Clin Nutr 2006;83:1313-20.
19. Hung DZ, Deng JF. Acute myocardial infarction temporally related to betel nut chewing. Vet Hum Toxicol 1998;40:25-8.
20. Deng JF, Ger J, Tsai WJ, Kao WF, Yang CC. Acute toxicities of betel nut: rare but probably overlooked events. J Toxicol Clin Toxicol 2001;39:355-60.
21. Chiang WT, Yang CC, Deng JF, Bullard M. Cardiac arrhythmia and betel nut chewing - is there a causal effect? Vet Hum Toxicol 1998;40:287-9.
22. Pan WH, Yeh WT, Chang HY, Hwu CM, Ho LT. Prevalence and awareness of diabetes and mean fasting glucose by age, sex, and region: results from the Nutrition and Health Survey in Taiwan, 1993-1996. Diabet Med 2003;20:182-5.
23. Pan WH, Kao MD, Tzeng MS, et al. Nutrition and health survey in Taiwan (NAHSIT) 1993-1996: design, contents, and operations. Nutr Sci J 1999;24:1-10.
24. Huang SL, Lin KC, Pan WH. Dietary factors associated with physician-diagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health Survey in Taiwan. Clin Exp Allergy 2001;31:259-64.
25. Pan WH, Chang YH, Chen JY, Wu SJ, Tzeng MS, Kao MD. Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996: dietary nutrient intakes assessed by 24-hour recall. Nutr Sci J 1999;24:11-40.
26. Department of Health. Nutrient composition data bank for foods of Taiwan area. Taipei, Taiwan: Department of Health, Republic of China, 1998.
27. Lin YC, Yen LL, Chen SY, et al. Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996. Prev Med 2003;37:233-41.
28. Pan WH, Yeh WT, Hwu CM, Ho LT. Undiagnosed diabetes mellitus in Taiwanese subjects with impaired fasting glycemia: impact of female sex, central obesity, and short stature. Chin J Physiol 2001;44:44-51.
29. Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 2004;79:31-9.
30. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-6.
31. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62.
32. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
33. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
34. LaVange LM, Koch GG, Schwartz TA. Applying sample survey methods to clinical trials data. Stat Med 2001;20:2609-23.
35. McNamee R. Regression modelling and other methods to control confounding. Occup Environ Med 2005;62:500-6.
36. Katz MH. Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003;138:644-50.
37. Schulz KF, Grimes DA. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet 2005;365:1657-61.
38. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
39. Goldberg IJ, Mosca L, Piano MR, Fisher EA. AHA Science Advisory: wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 2001;103:472-5.
40. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
41. Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005;68:1722-8.
42. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006;5:425-38.
43. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004;26:637-44.
44. Chu NS. Neurological aspects of areca and betel chewing. Addict Biol 2002;7:111-4.
45. Phillips JK. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol 2005;32:415-8.
46. Landsberg L. Feast or famine: the sympathetic nervous system response to nutrient intake. Cell Mol Neurobiol. 2006;26:497-508.
47. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006;7:335-46.
48. Kaaja RJ, Poyhonen-Alho MK. Insulin resistance and sympathetic over-activity in women. J Hypertens 2006;24:131-41.
49. Seals DR, Dinenno FA. Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol 2004;287:H1895-905.
50. Paton JF, Boscan P, Pickering AE, Nalivaiko E. The yin and yang of cardiac autonomic control: vago-sympathetic interactions revisited. Brain Res Brain Res Rev 2005;49:555-65.
51. Chen SJ, Wu BN, Yeh JL, Lo YC, Chen IS, Chen IJ. C-fiber-evoked autonomic cardiovascular effects after injection of Piper betle inflorescence extracts. J Ethnopharmacol 1995;45:183-8.
52. Clarke SP, Cossette S. Secondary analysis: theoretical, methodological, and practical considerations. Can J Nurs Res 2000;32:109-29.